{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:54:56Z","timestamp":1792896896459,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":461,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1038\/s41379-021-00835-5","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T11:04:22Z","timestamp":1623755062000},"page":"1839-1849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The sentinel node invasion level (SNIL) as a prognostic parameter in melanoma"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3260-5410","authenticated-orcid":false,"given":"Lutz","family":"Kretschmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Mitteldorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Hellriegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Leha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Fichtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Str\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Bremmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-021-00835-5_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1245\/s10434-019-07830-w","article-title":"The landmark series: MSLT-1, MSLT-2 and DeCOG (management of lymph nodes)","volume":"27","author":"Bello","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-021-00835-5_bib2","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","article-title":"Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy","volume":"375","author":"Eggermont","year":"2016","journal-title":"N. Engl J Med"},{"key":"10.1038\/s41379-021-00835-5_bib3","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N. Engl J Med"},{"key":"10.1038\/s41379-021-00835-5_bib4","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N. Engl J Med"},{"key":"10.1038\/s41379-021-00835-5_bib5","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/s41379-021-00835-5_bib6","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/annonc\/mdl176","article-title":"Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?","volume":"17","author":"van Akkooi","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-021-00835-5_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/SLA.0b013e3181b1735b","article-title":"Comparison of three micromorphometric pathology classifications of melanoma metastases in the sentinel node","volume":"250","author":"van der Ploeg","year":"2009","journal-title":"Ann Surg"},{"key":"10.1038\/s41379-021-00835-5_bib8","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N. Engl J Med"},{"key":"10.1038\/s41379-021-00835-5_bib9","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.18.02306","article-title":"Final analysis of DeCOG-SLT trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node","volume":"37","author":"Leiter","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00835-5_bib10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/SLA.0b013e31818fefe0","article-title":"Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes","volume":"248","author":"van Akkooi","year":"2008","journal-title":"Ann Surg"},{"key":"10.1038\/s41379-021-00835-5_bib11","doi-asserted-by":"crossref","first-page":"162S","DOI":"10.1245\/ASO.2004.12.920","article-title":"Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma","volume":"11","author":"Starz","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-021-00835-5_bib12","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/ijc.30563","article-title":"Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas","volume":"140","author":"Baum","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1038\/s41379-021-00835-5_bib13","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1200\/JCO.2004.12.177","article-title":"The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement","volume":"22","author":"Dewar","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00835-5_bib14","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1200\/JCO.2007.15.4179","article-title":"Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma","volume":"26","author":"Gershenwald","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00835-5_bib15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1309\/TDWJTR15TDM1TG7Q","article-title":"Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma","volume":"122","author":"Scolyer","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-021-00835-5_bib16","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1245\/s10434-008-9888-z","article-title":"Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes","volume":"15","author":"Satzger","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-021-00835-5_bib17","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1002\/cncr.25074","article-title":"Comparison of classification systems in melanoma sentinel lymph nodes-an analysis of 697 patients from a single center","volume":"116","author":"Meier","year":"2010","journal-title":"Cancer"},{"key":"10.1038\/s41379-021-00835-5_bib18","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1002\/cncr.24298","article-title":"Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma","volume":"115","author":"Murali","year":"2009","journal-title":"Cancer"},{"key":"10.1038\/s41379-021-00835-5_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/01926230600867727","article-title":"Normal structure, function, and histology of lymph nodes","volume":"34","author":"Willard-Mack","year":"2006","journal-title":"Toxicol Pathol"},{"key":"10.1038\/s41379-021-00835-5_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00259-014-2914-4","article-title":"The impact of nodal tumour burden on lymphoscintigraphic imaging in patients with melanomas","volume":"42","author":"Kretschmer","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1038\/s41379-021-00835-5_bib21","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/modpathol.2009.137","article-title":"Cutting a sentinel lymph node into slices is the optimal first step for examination of sentinel lymph nodes in melanoma patients","volume":"22","author":"Mitteldorf","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00835-5_bib22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/01926230590934304","article-title":"STP position paper: best practice guideline for the routine pathology evaluation of the immune system","volume":"33","author":"Haley","year":"2005","journal-title":"Toxicol Pathol"},{"key":"10.1038\/s41379-021-00835-5_bib23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejca.2005.10.023","article-title":"High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma","volume":"42","author":"van Akkooi","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41379-021-00835-5_bib24","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/ddg.13247","article-title":"S3-leitlinie diagnostik, therapie und nachsorge des melanoms - update 2015\/2016, Kurzversion 2.0","volume":"15","author":"Eigentler","year":"2017","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1038\/s41379-021-00835-5_bib25","doi-asserted-by":"crossref","first-page":"e94781","DOI":"10.1371\/journal.pone.0094781","article-title":"Mapping the distinctive populations of lymphatic endothelial cells in different zones of human lymph nodes","volume":"9","author":"Park","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1038\/s41379-021-00835-5_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2019.03.010","article-title":"An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma","volume":"114","author":"Cook","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41379-021-00835-5_bib27","doi-asserted-by":"crossref","unstructured":"Borgognoni L, Bellucci F, Urso C, Manneschi G, Gerlini G, Brandani P, et al. Enhancing the prognostic role of melanoma sentinel lymph nodes through microscopic tumour burden characterization: clinical usefulness in patients who do not undergo complete lymph node dissection. Melanoma Res. 2018. https:\/\/doi.org\/10.1097\/cmr.0000000000000481.","DOI":"10.1097\/CMR.0000000000000481"},{"key":"10.1038\/s41379-021-00835-5_bib28","doi-asserted-by":"crossref","unstructured":"Seth R, Messersmith H, Kaur V, Kirkwood JM, Kudchadkar R, McQuade JL, et al. Systemic therapy for melanoma: ASCO guideline. J Clin Oncol. 2020. https:\/\/doi.org\/10.1200\/jco.20.00198.","DOI":"10.1200\/JCO.20.00198"},{"key":"10.1038\/s41379-021-00835-5_bib29","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/PAS.0b013e3180341ebc","article-title":"Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes","volume":"31","author":"Satzger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00835-5_bib30","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/PAS.0b013e318162442e","article-title":"The prognostic significance of isolated immunohistochemically positive cells in sentinel lymph nodes of melanoma patients","volume":"32","author":"Murali","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00835-5_bib31","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.ejca.2010.06.003","article-title":"EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria","volume":"46","author":"van der Ploeg","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41379-021-00835-5_bib32","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1245\/s10434-007-9472-y","article-title":"Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma","volume":"14","author":"Scheri","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-021-00835-5_bib33","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4236\/jct.2013.410180","article-title":"The prognostic value of minimally involved melanoma","volume":"4","author":"Saadi","year":"2013","journal-title":"J Cancer Ther"},{"key":"10.1038\/s41379-021-00835-5_bib34","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1245\/s10434-011-2208-z","article-title":"Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative","volume":"19","author":"Murali","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-021-00835-5_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejca.2013.08.023","article-title":"The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients","volume":"50","author":"van der Ploeg","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41379-021-00835-5_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/PPO.0000000000000087","article-title":"Pathologic evaluation of sentinel nodes","volume":"21","author":"Messina","year":"2015","journal-title":"Cancer J"},{"key":"10.1038\/s41379-021-00835-5_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1346-8138.2011.01318.x","article-title":"Prediction of additional lymph node positivity and clinical outcome of micrometastases in sentinel lymph nodes in cutaneous melanoma: a multi-institutional study of 450 patients in Japan","volume":"39","author":"Namikawa","year":"2012","journal-title":"J Dermatol"},{"key":"10.1038\/s41379-021-00835-5_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejca.2011.08.019","article-title":"Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study","volume":"48","author":"Riber-Hansen","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41379-021-00835-5_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejca.2019.07.004","article-title":"Melanoma-specific survival in patients with positive sentinel lymph nodes: relevance of sentinel tumor burden","volume":"123","author":"Satzger","year":"2019","journal-title":"Eur J Cancer"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00835-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00835-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00835-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:34:01Z","timestamp":1760229241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222005294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0893395222005294"],"URL":"https:\/\/doi.org\/10.1038\/s41379-021-00835-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740415905.793589253","asserted-by":"object"}]},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The sentinel node invasion level (SNIL) as a prognostic parameter in melanoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-021-00835-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}